Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

VYGR holding history

Voyager Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VYGR overviewAll 13F holders of VYGRFull Q2 2026 holdings

Shares (Q2 2026)
42,786
Value
$149.8K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of VYGR by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202642,786$149.8K<0.1%−51,893−54.8%ReducedHolders
Q1 202694,679$365.5K<0.1%−174,114−64.8%ReducedHolders
Q4 2025268,793$1.06M<0.1%−204,307−43.2%ReducedHolders
Q3 2025473,100$2.21M<0.1%+17,558+3.9%AddedHolders
Q2 2025455,542$1.42M<0.1%+99,610+28.0%AddedHolders
Q1 2025355,932$1.20M<0.1%+156,622+78.6%AddedHolders
Q4 2024199,310$1.13M<0.1%+175,047+721.5%AddedHolders
Q3 202424,263$141.9K<0.1%−34,229−58.5%ReducedHolders
Q2 202458,492$462.7K<0.1%−45,792−43.9%ReducedHolders
Q1 2024104,284$970.9K<0.1%+71,590+219.0%AddedHolders
Q4 202332,694$275.9K<0.1%+18,535+130.9%AddedHolders
Q3 202314,159$109.7K<0.1%−11,678−45.2%ReducedHolders
Q2 202325,837$295.8K<0.1%+20,785+411.4%AddedHolders
Q1 20235,052$39.0K<0.1%+5,052NewHolders
Q4 20220$00.0%−2,703−100.0%Sold outHolders
Q3 20222,703$16.0K<0.1%+2,492+1,181.0%AddedHolders
Q2 2022211$1.00K<0.1%−3,914−94.9%ReducedHolders
Q1 20224,125$31.0K<0.1%−2,528−38.0%ReducedHolders
Q4 20216,653$18.0K<0.1%−181,868−96.5%ReducedHolders
Q3 2021188,521$496.0K<0.1%+42,422+29.0%AddedHolders
Q2 2021146,099$603.0K<0.1%+3,614+2.5%AddedHolders
Q1 2021142,485$672.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.